Thrombomodulin: An overview and potential implications in vascular disorders

Lupus - Tập 7 Số 2_suppl - Trang 120-125 - 1998
Marie‐Claire Boffa1, Marina Karmochkine1
1INSERM U 353, Institut d'Hématologie, Hôpital Saint-Louis, and Service d'Immunologie Clinique, Hôpital Broussais, Paris, France

Tóm tắt

Thrombomodulin (TM), a high affinity thrombin receptor present on endothelial cell membrane, plays an important role as a natural anticoagulant. It acts as a cofactor of thrombin-catalyzed activation of protein C, and inhibits the procoagulant functions of thrombin. TM is also located in other cells (keratinocytes, osteoblasts, macrophages, …) where it might be involved in cell differentiation or in inflammation. In the presence of cytokines, activated neutrophils and macrophages, endothelial TM is cleaved enzymatically, releasing soluble fragments which circulate in the blood and are eliminated in urine. Plasma TM level (pTM) can be measured using a two-site enzyme-linked immunosorbent assay (ELISA). pTM level is regarded as a molecular marker reflecting injury of endothelial cells. It is often increased in case of diffuse endothelial damage as in disseminated intravascular coagulation, diabetic microangiopathy, Plasmodium falciparum and rickettsial infections. pTM is also a predictive marker of hypertensive complications in pregnancy. In several systemic inflammatory diseases, pTM levels are correlated to the activity of the disease.

Từ khóa


Tài liệu tham khảo

10.1096/fasebj.9.10.7615164

Bourin MC, 1990, J Biol Chem, 265, 15424, 10.1016/S0021-9258(18)55414-4

10.1021/bi00388a025

10.1182/blood.V89.2.652

10.1016/S0166-6851(97)00082-0

10.1073/pnas.78.4.2249

10.1074/jbc.270.24.14477

Grey ST, 1996, J Immunol, 156, 2256, 10.4049/jimmunol.156.6.2256

10.1006/scel.1995.0035

Boehme MWJ, 1996, Immunology, 87, 134

10.1016/0012-1606(90)90058-Q

10.1172/JCI117171

10.1007/s004030050171

Boffa MC., 1996, Haemostasis, 26, 233

10.1083/jcb.101.2.363

Boffa MC, 1991, Nouv Rev Fr Hematol, 33, 423

10.1177/35.11.2821107

10.1038/ki.1997.99

10.1182/blood.V78.12.3128.3128

10.1182/blood.V80.5.1254.1254

10.1210/endo.133.2.8393772

10.1002/(SICI)1098-1136(199703)19:3<259::AID-GLIA8>3.0.CO;2-U

10.1006/excr.1997.3812

10.1172/JCI112225

10.1055/s-0038-1648199

Abe H, 1994, J Lab Clin Med, 123, 874

10.1182/blood.V76.10.2024.2024

10.1016/0009-8981(90)90221-D

10.1055/s-0038-1645037

10.1089/hyb.1994.13.205

Boffa MC, 1991, Blood, 78, 221

10.1046/j.1365-2141.1996.d01-1486.x

10.1055/s-0037-1614943

10.1055/s-0037-1615021

10.1016/S0002-9343(96)80070-2

10.1055/s-0038-1650651

10.1055/s-0038-1648889

10.1182/blood.V82.7.2109.2109

10.1093/clinchem/37.2.269

10.1002/(SICI)1096-8652(199710)56:2<93::AID-AJH4>3.0.CO;2-W

10.1002/ajh.2830380406

10.1016/0049-3848(95)00207-3

10.1002/ajh.2830380304

10.1002/ajh.2830390106

10.1016/0028-2243(95)02093-8

10.1016/0029-7844(95)00326-M

10.1093/bja/74.2.174

10.1097/00001721-199504000-00007

10.1016/0049-3848(93)90116-6

10.1046/j.1365-2362.1997.2180766.x

Seigneur M, 1995, Nouv Rev Fr Hematol, 37, 171

10.1161/01.ATV.17.3.505

10.1161/01.ATV.17.11.2646

10.1161/01.CIR.96.9.2938

10.1093/oxfordjournals.eurheartj.a014713

Takaya M, 1991, Clin Exp Rheumatol, 9, 495

10.1182/blood.V79.3.837.837

Kawakami M, 1992, J Rheumatol, 19, 1704

10.1093/ajcp/101.1.109

10.1016/0167-5273(94)90319-0

10.1002/art.1780370419

10.1159/000204590

10.1055/s-0038-1646304

Kotajima L, 1997, Clin Exp Rheumatol, 15, 59

Mercié P, 1995, J Rheumatol, 22, 1444

10.1378/chest.106.3.666

10.1016/S0002-9343(96)00230-6

Thông tin
Thông tin xuất bản

Lupus

Tập 7 Số 2_suppl

120-125

Thông tin tác giả